Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels in Diabetic Women

NCT00522470 is registered in ClinicalTrials.gov with Baskent University as lead sponsor.

NCT NCT00522470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00522470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels in Diabetic Women
Lead sponsor
Baskent University
Phase
Phase 4
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type 2 diabetes mellitus